Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Dec. 2025,
Ramsay Health Care paidA$0 Mil more to buy back shares than it received from issuing new shares.
It receivedA$156 Mil from issuing more debt.
It paidA$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spentA$113 Mil paying cash dividends to shareholders.
It spentA$296 Mil on other financial activities.
In all, Ramsay Health CarespentA$254 Mil on financial activities for the
six
months ended in Dec. 2025.
Ramsay Health Care (ASX:RHC) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Ramsay Health Care's issuance of stock for the
six
months ended in Dec. 2025 was A$0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Ramsay Health Care's repurchase of stock for the
six
months ended in Dec. 2025 was A$0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Ramsay Health Care's net issuance of debt for the
six
months ended in Dec. 2025 was A$156 Mil.
Ramsay Health Care receivedA$156 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Ramsay Health Care's net issuance of preferred for the
six
months ended in Dec. 2025 was A$0 Mil.
Ramsay Health Care paidA$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Ramsay Health Care's cash flow for dividends for the
six
months ended in Dec. 2025 was A$-113 Mil.
Ramsay Health Care spentA$113 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Ramsay Health Care's other financing for the
six
months ended in Dec. 2025 was A$-296 Mil.
Ramsay Health Care spentA$296 Mil on other financial activities.
Ramsay Health Care Cash Flow from Financing Related Terms
Ramsay Health Care Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Ramsay Health Care's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Ramsay Health Care's Cash from Financing for the fiscal year that ended in Jun. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-621 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of A$-621 Mil mean?
Ramsay Health Care (ASX:RHC) has a Cash Flow from Financing of A$-621 Mil as of Dec. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Ramsay Health Care and its competitors.
Is Ramsay Health Care's Cash Flow from Financing too high?
Ramsay Health Care's current Cash Flow from Financing is A$-621 Mil. Overall, Ramsay Health Care has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Cash Flow from Financing compare to HCA and THC?
Ramsay Health Care's Cash Flow from Financing of A$-621 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Ramsay Health Care and its competitors. Ramsay Health Care's current Cash Flow from Financing is A$-621 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.81, compared to a current price of A$41.95 — trading 17.4% below its estimated fair value. The current Cash Flow from Financing is A$-621 Mil. Ramsay Health Care's overall GF Score™ is 88/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Cash Flow from Financing is A$-621 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued.
The current stock price of A$41.95 is trading 17.4% below its estimated GF Value™ of A$50.81.
GuruFocus considers Ramsay Health Care to be Modestly Undervalued.
Key valuation signals for ASX:RHC:
Cash Flow from Financing: A$-621 Mil
GF Value™: A$50.81 vs. price of A$41.95 (17.4% below fair value)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
88GF Score
Get the complete analysis for ASX:RHC
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
